Dong Feng Chen, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Detachment | 6 | 2008 | 426 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2005 | 1410 | 0.560 |
Why?
|
| Astrocytes | 6 | 2008 | 1345 | 0.530 |
Why?
|
| Central Nervous System | 3 | 2008 | 1341 | 0.500 |
Why?
|
| Nerve Regeneration | 4 | 2005 | 802 | 0.490 |
Why?
|
| Photoreceptor Cells, Vertebrate | 5 | 2008 | 203 | 0.460 |
Why?
|
| Retina | 7 | 2008 | 2657 | 0.450 |
Why?
|
| Glial Fibrillary Acidic Protein | 5 | 2008 | 564 | 0.410 |
Why?
|
| Axons | 3 | 2005 | 1682 | 0.390 |
Why?
|
| Retinal Ganglion Cells | 4 | 2006 | 810 | 0.350 |
Why?
|
| Vimentin | 3 | 2007 | 258 | 0.320 |
Why?
|
| Ephrins | 1 | 2008 | 28 | 0.300 |
Why?
|
| Mucin-1 | 7 | 2007 | 531 | 0.300 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2008 | 32 | 0.290 |
Why?
|
| Retinal Degeneration | 3 | 2008 | 413 | 0.270 |
Why?
|
| Neuroglia | 3 | 2008 | 964 | 0.250 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2008 | 450 | 0.250 |
Why?
|
| Integrin alpha1beta1 | 1 | 2004 | 8 | 0.230 |
Why?
|
| Integrin alpha2beta1 | 1 | 2004 | 17 | 0.230 |
Why?
|
| Photobleaching | 1 | 2004 | 29 | 0.230 |
Why?
|
| Neurons | 4 | 2008 | 9525 | 0.220 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 5 | 2008 | 425 | 0.220 |
Why?
|
| Laminin | 1 | 2004 | 404 | 0.200 |
Why?
|
| Luminescent Measurements | 1 | 2004 | 341 | 0.200 |
Why?
|
| Lithium Chloride | 1 | 2003 | 82 | 0.200 |
Why?
|
| Apoptosis | 5 | 2006 | 9514 | 0.190 |
Why?
|
| Cell Differentiation | 3 | 2008 | 11641 | 0.190 |
Why?
|
| Ureter | 1 | 2004 | 364 | 0.190 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2005 | 354 | 0.190 |
Why?
|
| Optic Nerve | 1 | 2005 | 567 | 0.190 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2007 | 610 | 0.180 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2003 | 498 | 0.170 |
Why?
|
| Calcium Signaling | 1 | 2005 | 733 | 0.170 |
Why?
|
| Dendritic Cells | 4 | 2004 | 2747 | 0.170 |
Why?
|
| Retinal Vessels | 1 | 2005 | 863 | 0.160 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 1118 | 0.160 |
Why?
|
| Mice, Transgenic | 7 | 2008 | 9550 | 0.150 |
Why?
|
| Stem Cells | 2 | 2008 | 3540 | 0.150 |
Why?
|
| Microglia | 2 | 2007 | 1372 | 0.140 |
Why?
|
| Coculture Techniques | 3 | 2008 | 1336 | 0.140 |
Why?
|
| Mice | 19 | 2008 | 81819 | 0.130 |
Why?
|
| Diabetic Retinopathy | 1 | 2005 | 1299 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 10 | 2008 | 22332 | 0.130 |
Why?
|
| Collagen | 1 | 2004 | 2618 | 0.130 |
Why?
|
| Cancer Vaccines | 1 | 2003 | 1044 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2004 | 1087 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2008 | 23601 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 4520 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 2878 | 0.110 |
Why?
|
| Biopsy | 1 | 2005 | 6763 | 0.100 |
Why?
|
| Animals | 20 | 2008 | 168764 | 0.100 |
Why?
|
| Cell Fusion | 4 | 2004 | 295 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5125 | 0.090 |
Why?
|
| DNA | 1 | 2004 | 7202 | 0.090 |
Why?
|
| Cell Nucleus | 4 | 2007 | 2867 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2007 | 5020 | 0.080 |
Why?
|
| Insulin | 1 | 2004 | 6599 | 0.080 |
Why?
|
| Antigens, Neoplasm | 3 | 2007 | 2002 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 4562 | 0.080 |
Why?
|
| Ephrin-A3 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Receptor, EphA7 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Ephrin-A2 | 1 | 2008 | 25 | 0.080 |
Why?
|
| Recoverin | 1 | 2008 | 11 | 0.080 |
Why?
|
| Gliosis | 2 | 2007 | 247 | 0.070 |
Why?
|
| Bromodeoxyuridine | 1 | 2008 | 310 | 0.070 |
Why?
|
| Chemokine CCL2 | 2 | 2007 | 602 | 0.070 |
Why?
|
| Mucins | 2 | 2007 | 567 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2004 | 1801 | 0.070 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2007 | 164 | 0.060 |
Why?
|
| Chickens | 1 | 2008 | 842 | 0.060 |
Why?
|
| beta Catenin | 3 | 2005 | 1043 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2007 | 14448 | 0.060 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 392 | 0.060 |
Why?
|
| Caspases | 2 | 2005 | 880 | 0.060 |
Why?
|
| Cell Movement | 4 | 2008 | 5194 | 0.060 |
Why?
|
| Cell Count | 2 | 2008 | 1823 | 0.060 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2004 | 49 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2005 | 317 | 0.060 |
Why?
|
| Integrin alpha6beta1 | 1 | 2004 | 19 | 0.060 |
Why?
|
| Mercaptoethanol | 1 | 2004 | 61 | 0.060 |
Why?
|
| Integrin alpha6beta4 | 1 | 2004 | 31 | 0.060 |
Why?
|
| Integrin alpha3beta1 | 1 | 2004 | 54 | 0.060 |
Why?
|
| Cell Transplantation | 2 | 2003 | 473 | 0.060 |
Why?
|
| Bacteriophage lambda | 1 | 2004 | 142 | 0.060 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2006 | 594 | 0.060 |
Why?
|
| Kidney Medulla | 1 | 2004 | 169 | 0.060 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2004 | 163 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 414 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 3 | 2007 | 3750 | 0.050 |
Why?
|
| Cell Survival | 2 | 2004 | 5747 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 774 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2005 | 414 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 684 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 710 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 858 | 0.050 |
Why?
|
| Pericytes | 1 | 2005 | 299 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2004 | 283 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2006 | 1243 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 499 | 0.050 |
Why?
|
| Capillaries | 1 | 2005 | 755 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2008 | 10429 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2008 | 1180 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 1966 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2004 | 697 | 0.050 |
Why?
|
| Antibodies, Neoplasm | 1 | 2003 | 282 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 2007 | 1744 | 0.050 |
Why?
|
| Transgenes | 1 | 2005 | 1015 | 0.050 |
Why?
|
| Models, Anatomic | 1 | 2005 | 677 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 1745 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2005 | 1228 | 0.040 |
Why?
|
| Hyperinsulinism | 1 | 2004 | 402 | 0.040 |
Why?
|
| DNA Primers | 1 | 2005 | 2825 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2627 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2005 | 1240 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2008 | 2920 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2002 | 616 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2002 | 579 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2669 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 2014 | 0.040 |
Why?
|
| Regeneration | 1 | 2008 | 1517 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2007 | 3690 | 0.040 |
Why?
|
| Muscles | 1 | 2004 | 1578 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 1132 | 0.040 |
Why?
|
| Lymphocyte Activation | 3 | 2004 | 5501 | 0.040 |
Why?
|
| Antigens | 1 | 2004 | 1438 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2006 | 4348 | 0.040 |
Why?
|
| Oncogenes | 1 | 2003 | 1235 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 2927 | 0.040 |
Why?
|
| Disease Progression | 2 | 2005 | 13632 | 0.030 |
Why?
|
| Cell Separation | 1 | 2003 | 1718 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2005 | 1747 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2007 | 18293 | 0.030 |
Why?
|
| Leukemia | 1 | 2004 | 1522 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2004 | 2195 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 6493 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2008 | 4913 | 0.030 |
Why?
|
| Rats | 3 | 2006 | 23707 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2008 | 18973 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2006 | 12768 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2007 | 924 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3607 | 0.030 |
Why?
|
| Time Factors | 2 | 2005 | 40065 | 0.030 |
Why?
|
| Recurrence | 1 | 2005 | 8501 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2007 | 939 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2004 | 3312 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 5767 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 3 | 2004 | 6113 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10729 | 0.020 |
Why?
|
| Mitochondria | 1 | 2004 | 3673 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2005 | 1500 | 0.020 |
Why?
|
| Humans | 13 | 2008 | 765968 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7599 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2004 | 1347 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 3807 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2002 | 4405 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2004 | 5337 | 0.020 |
Why?
|
| Neurocan | 1 | 2008 | 21 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2008 | 159 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 2 | 2003 | 1325 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2004 | 3089 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2007 | 42 | 0.020 |
Why?
|
| beta Karyopherins | 1 | 2007 | 46 | 0.020 |
Why?
|
| Mice, Nude | 2 | 2003 | 3618 | 0.020 |
Why?
|
| Brain | 2 | 2005 | 27171 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 914 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2006 | 229 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 431 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2005 | 3421 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2005 | 4137 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2008 | 793 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2008 | 1644 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 612 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 576 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 10261 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2002 | 5197 | 0.010 |
Why?
|
| Trans-Activators | 2 | 2003 | 2850 | 0.010 |
Why?
|
| Carcinogenicity Tests | 1 | 2003 | 39 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2003 | 116 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 833 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2004 | 173 | 0.010 |
Why?
|
| Protein Binding | 2 | 2007 | 9296 | 0.010 |
Why?
|
| Neuregulin-1 | 1 | 2004 | 140 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 195 | 0.010 |
Why?
|
| HCT116 Cells | 1 | 2003 | 399 | 0.010 |
Why?
|
| Female | 4 | 2005 | 396112 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2006 | 2266 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 713 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2002 | 318 | 0.010 |
Why?
|
| Male | 5 | 2007 | 363698 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2002 | 511 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2003 | 449 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 731 | 0.010 |
Why?
|
| Plasmacytoma | 1 | 2002 | 174 | 0.010 |
Why?
|
| Obesity | 1 | 2004 | 13076 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 2002 | 228 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 54802 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 1727 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 1672 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2003 | 1524 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3797 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 3067 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2003 | 722 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 827 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 1151 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 4165 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 22340 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 5743 | 0.010 |
Why?
|
| Monocytes | 1 | 2007 | 2595 | 0.010 |
Why?
|
| Cisplatin | 1 | 2004 | 1658 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2002 | 1391 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1652 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 2412 | 0.010 |
Why?
|
| Adolescent | 1 | 2005 | 88835 | 0.010 |
Why?
|
| Aged | 2 | 2005 | 171117 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 4392 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 6001 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 8278 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 7584 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 6274 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3634 | 0.010 |
Why?
|
| DNA Damage | 1 | 2004 | 2457 | 0.010 |
Why?
|
| Middle Aged | 2 | 2005 | 223009 | 0.010 |
Why?
|
| Adult | 2 | 2005 | 223044 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5881 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 6220 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 4159 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11022 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 5786 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13400 | 0.010 |
Why?
|
| Mutation | 2 | 2007 | 30198 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 17075 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 3454 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2004 | 4752 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 8611 | 0.000 |
Why?
|
| Cytokines | 1 | 2002 | 7421 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 11888 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2003 | 12131 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13648 | 0.000 |
Why?
|